XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 12,842 $ 18,787
General and administrative 7,357 7,734
Total operating expenses 20,199 26,521
Loss from operations (20,199) (26,521)
Other income (expense):    
Interest income 7,130 4,979
Investment advisory fees (265) (230)
Change in fair value of warrant liability (1,459) 142
Net (loss) gain on marketable securities 1 (96)
Total other income (expense), net 5,407 4,795
Loss before income taxes (14,792) (21,726)
Provision for income taxes 0 0
Net loss $ (14,792) $ (21,726)
Net loss per share attributable to common stockholders, basic $ (0.07) $ (0.1)
Net loss per share attributable to common stockholders, diluted $ (0.07) $ (0.1)
Weighted average common shares outstanding, basic 219,048 218,741
Weighted average common shares outstanding, diluted 219,048 218,741
Comprehensive loss:    
Net loss $ (14,792) $ (21,726)
Other comprehensive loss, net of taxes:    
Unrealized gain (loss) on available-for-sale securities, net (1,350) 2,588
Comprehensive loss $ (16,142) $ (19,138)